Tarek Hassanein, MD, FACP, FACG, AGAF, FAASLD, is a board-certified in Internal Medicine, Gastroenterology, and Transplant Hepatology. Dr. Hassanein specializes in treating viral hepatitis, fatty liver disease and cirrhosis, and in caring for patients before and after liver transplantation. Dr. Hassanein is a Professor of Medicine at the University of California San Diego School of Medicine. Dr. Hassanein was instrumental in establishing three major liver transplant programs.

Dr. Oliver is Board-Certified in Internal Medicine. She received her BS in Biology from University of California San Diego, and her MBA from Webster University, and her Doctor of Medicine from AUC School of Medicine. Dr. Oliver finished her residency in Internal Medicine at the University of California Fresno and became the Chief Resident and then Assistant Program Director of the Internal Medicine Residency Program.

Prior to joining SCLC, she participated in the care of patients with COVID-19, helping to develop the first Hospital-at-Home Program in California at Adventist Hospital system. She joined SCLC as a Consultant Hepatologist and is the Chief of Inpatient Hepatology Services. Dr. Oliver has extensive experience in liver research and is the Associate Director of Research at Southern California Research Center. Her focus is on the management of end stage liver disease and directs the Palliative Care Program at SCLC.

Dr. Roukaya T. Hassanein is a board-certified general surgeon with extensive experience in a broad spectrum of surgical conditions. She specializes in minimally invasive surgical techniques, open procedures, and endoscopy, enabling her to treat a wide range of diseases. Her surgical expertise encompasses procedures involving the alimentary tract, abdomen, breast, skin and soft tissue, and vascular system.

Dr. Hassanein earned her Doctor of Medicine degree in 2017 and has since accumulated over seven years of diverse surgical experience. She holds medical licenses in both California and Ohio, reflecting her commitment to providing high-quality surgical care across different regions.

Dedicated to patient-centered care, Dr. Hassanein expertly manages all aspects of patient care, including preoperative evaluation, operative intervention, and postoperative management. Her comprehensive approach ensures that patients receive personalized treatment tailored to their specific needs.

Dr. Hassanein's commitment to advancing surgical care and her comprehensive approach to patient management make her a valuable asset to the medical community

Dr. Kevin Burns is a board-certified interventional radiologist specializing in minimally invasive, image-guided treatments for liver cancer and gastrointestinal disorders. With expertise in procedures such as transarterial chemoembolization (TACE), radiofrequency ablation (RFA), and Yttrium-90 (Y-90) radioembolization, he effectively targets liver tumors to maximize patient outcomes while minimizing side effects.

In addition to his work in liver cancer, Dr. Burns is proficient in gastrointestinal interventions like portal vein embolization and transjugular intrahepatic portosystemic shunt (TIPS) placement, which are crucial in managing complications of liver disease and portal hypertension.

Dr. Burns completed his undergraduate studies in biochemistry and molecular biology at Brown University and earned his medical degree from New York University School of Medicine. He completed his residency at Montefiore Medical Center/Albert Einstein College of Medicine and advanced his specialization through a fellowship in interventional radiology and oncology at MD Anderson Cancer Center. Committed to improving patient care, Dr. Burns brings cutting-edge, minimally invasive therapies to those affected by liver and gastrointestinal conditions.